← Back to Search

YES-ERACE Curriculum for Reducing Youth Violence (YES-ERACE Trial)

N/A
Recruiting
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (0 months), end of program (3 months), 6 months, 9 months, 12 months
Awards & highlights

YES-ERACE Trial Summary

This trial will test whether the YES-ERACE curriculum, which focuses on empowering youth to address racism and racial discrimination, can reduce violent behavior, including race-based victimization.

Who is the study for?
This trial is for middle school students in grades 6-8 who are part of after-school programs at six schools within the Genesee County Intermediate School District. Participants must agree to join; those who don't or whose parents refuse cannot participate.Check my eligibility
What is being tested?
The study tests YES-ERACE, an adapted curriculum aimed at empowering youth to tackle racism and reduce violence, against regular after-school activities. It measures how well it boosts empowerment, anti-racist behavior, and decreases violent acts among students.See study design
What are the potential side effects?
Since this intervention involves educational programming rather than medical treatment, traditional side effects are not applicable. However, participants may experience changes in attitudes or behaviors related to race and empowerment.

YES-ERACE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (0 months), end of program (3 months), 6 months, 9 months, 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (0 months), end of program (3 months), 6 months, 9 months, 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Bystander behaviors
Change in Privilege awareness
Change in Prosocial behaviors
+6 more

YES-ERACE Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: YES-ERACEExperimental Treatment1 Intervention
Students participate in the YES-ERACE program.
Group II: ControlActive Control1 Intervention
Students participate in the regular after-school programming.

Find a Location

Who is running the clinical trial?

University of MichiganLead Sponsor
1,796 Previous Clinical Trials
6,377,586 Total Patients Enrolled
National Institute on Minority Health and Health Disparities (NIMHD)NIH
383 Previous Clinical Trials
1,215,841 Total Patients Enrolled

Media Library

YES-ERACE Clinical Trial Eligibility Overview. Trial Name: NCT05337410 — N/A
Treatment Research Study Groups: YES-ERACE, Control
Treatment Clinical Trial 2023: YES-ERACE Highlights & Side Effects. Trial Name: NCT05337410 — N/A
YES-ERACE 2023 Treatment Timeline for Medical Study. Trial Name: NCT05337410 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it feasible for me to participate in this investigation?

"The study is recruiting 370 minors aged 10-15 and residing within Genesee County Intermediate School District who are enrolled in afterschool programs, between the 6th to 8th grade, and have given assent."

Answered by AI

How many participants are included in the present clinical experiment?

"Correct. According to clinicaltrials.gov, the trial is still actively recruiting participants and has been so since June 1st 2021 when it was first posted. The listing was last updated on April 19th 2022 indicating that 370 patients need to be recruited from one location for this study."

Answered by AI

Is the current research seeking out individuals aged 35 and over?

"This trial is open to people aged 10-15. There are also other clinical trials available for patients who do not meet this age criteria: there are 10 studies that include participants under 18 and 27 research projects reserved for those above 65 years of age."

Answered by AI

Is it still feasible to join this experiment?

"Affirmative. Online information from clinicaltrials.gov shows that, following a June 2021 post and April 2022 update, this medical trial is actively recruiting for 370 participants at one site."

Answered by AI
~100 spots leftby Jun 2025